Medicare Enrolled

Dr. Audrey Miklius, M.D.

Endocrinology · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
10260 N CENTRAL EXPY STE 100N, Dallas, TX 75231
2143635535
In practice since 2006 (19 years)
NPI: 1689628257 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Miklius from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Miklius? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Miklius

Dr. Audrey Miklius is an endocrinology in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Miklius performed 4,789 Medicare services across 3,070 unique beneficiaries.

Between the years covered by Open Payments, Dr. Miklius received a total of $59,420 from 73 pharmaceutical and/or device companies across 1104 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Miklius is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 9% volume in TX$ $59,420 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,789
Medicare services
Top 9% in TX for endocrinology
3,070
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~252 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)833$86$236
Blood draw (venipuncture)597$8$12
Comprehensive metabolic blood panel581$10$57
Thyroid stimulating hormone (TSH) test513$16$49
Lipid panel (cholesterol and triglycerides)483$13$54
Free thyroxine (T4) test436$9$86
Hemoglobin A1c test (diabetes monitoring)421$10$47
Complete blood count (CBC) with differential290$8$20
Bone density scan (DEXA)122$38$317
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report117$25$77
Diabetes outpatient self-management training services, individual, per 30 minutes115$40$125
Office visit, established patient, complex (40-54 min)51$129$311
Thyroid hormone, t3 measurement, total47$14$87
Basic metabolic blood panel21$8$37
Testosterone (hormone) level, total19$25$130
Sex hormone binding globulin (protein) level18$21$58
Testosterone (hormone) level, free18$25$110
Parathyroid hormone level test17$40$141
Flu vaccine, quadrivalent17$76$174
New patient office visit, complex (60-74 min)17$153$449
Flu vaccine administration17$31$40
Thyroid hormone evaluation16$6$22
Automated urinalysis12$2$13
Thyroxine (thyroid chemical), total11$7$25
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$59,420
Total received (2018-2024)
Avg $8,489/year across 7 years
Top 14% in TX for endocrinology
73
Companies
1,104
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$35,816 (60.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,510 (31.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,094 (8.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,258
2023
$3,113
2022
$2,622
2021
$1,944
2020
$19,664
2019
$17,320
2018
$11,500

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$12,365
Lilly USA, LLC
$12,063
Boehringer Ingelheim Pharmaceuticals, Inc.
$10,897
Tandem Diabetes Care, Inc.
$7,633
Gilead Sciences, Inc.
$1,844
AstraZeneca Pharmaceuticals LP
$1,450
Amgen Inc.
$1,384
Radius Health, Inc.
$1,165
Abbott Laboratories
$853
Mannkind Corporation
$627
Insulet Corporation
$605
SANOFI-AVENTIS U.S. LLC
$592
MannKind Corporation
$581
Alexion Pharmaceuticals, Inc.
$501
Amarin Pharma Inc.
$501
Xeris Pharmaceuticals, Inc.
$421
Dexcom, Inc.
$378
DEXCOM, INC.
$323
Medtronic MiniMed, Inc.
$275
Janssen Pharmaceuticals, Inc
$256
Shire North American Group Inc
$251
Medtronic, Inc.
$248
Antares Pharma, Inc.
$247
AbbVie, Inc.
$232
Bayer HealthCare Pharmaceuticals Inc.
$208
ABBVIE INC.
$186
Amneal Pharmaceuticals LLC
$183
Merck Sharp & Dohme Corporation
$175
Kyowa Kirin, Inc.
$165
PFIZER INC.
$138
Averitas Pharma Inc.
$131
Alvogen Inc
$127
CeQur Corporation
$118
Corcept Therapeutics
$117
Regeneron Healthcare Solutions, Inc.
$116
Amryt Pharma Holdings Ltd
$114
Merck Sharp & Dohme LLC
$113
Eton Pharmaceuticals, Inc.
$112
IBSA Pharma Inc.
$107
Embecta Corp.
$97
Valeritas, Inc.
$95
AbbVie Inc.
$93
Ascendis Pharma Inc
$92
Currax Pharmaceuticals LLC
$86
Senseonics, Incorporated
$78
SHIELD THERAPEUTICS INC
$73
Neurocrine Biosciences, Inc.
$69
Avvisto Therapeutics, LLC
$63
GRT US Holding, Inc.
$61
VIVUS, Inc.
$58
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$58
Ultragenyx Pharmaceutical Inc.
$57
Becton, Dickinson and Company
$56
BETA BIONICS, INC.
$53
Horizon Therapeutics plc
$52
Chiesi USA, Inc.
$48
Companion Medical, Inc.
$46
EISAI INC.
$45
Novartis Pharmaceuticals Corporation
$34
Bayer Healthcare Pharmaceuticals Inc.
$31
Nalpropion Pharmaceuticals LLC
$31
Rhythm Pharmaceuticals, Inc.
$27
Aytu BioScience, Inc
$27
Gemini Laboratories, LLC
$26
Eisai Inc.
$26
Strongbridge US INC.
$26
Ipsen Biopharmaceuticals, Inc
$22
Nalpropion Pharmaceuticals, Inc.
$18
LIFESCAN, INC.
$16
LifeScan, Inc.
$15
Zealand Pharma US, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$14
Ascensia Diabetes Care US Inc.
$13
Top 3 companies account for 59.4% of total payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · Alkindi · Androgel · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BYDUREON · Belviq · CONTRAVE · CRENESSITY · CRYSVITA · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · Enlite Sensor · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · LINZESS · Livalo · MACRILEN · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · NanoCross · Natesto · OTREXUP · Omnipod · OneTouch · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 20 · Prolia · QSYMIA · QUTENZA · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Skytrofa · Sogroya · Somatuline Depot · Strensiq · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tymlos · UBRELVY · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · Wegovy · XYOSTED · Xultophy 100/3.6 · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (60%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $1,241 per 100 Medicare services performed
Looking for a endocrinology in Dallas?
Compare endocrinologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
97
Per 100K population
3.7
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Miklius is a clinical cardiology specialist, with above-average Medicare volume (top 9% in TX), and high industry engagement (speaking/promotional, top 14%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Miklius experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Miklius performed 833 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Miklius receive payments from pharmaceutical companies?
Yes. Dr. Miklius received a total of $59,420 from 73 companies across 1,104 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Miklius's costs compare to other endocrinologys in Dallas?
Dr. Miklius's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Miklius) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →